-
81
Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
Published 2020-01-01“…The recent outbreak of the novel coronavirus disease, COVID-19, has highlighted the threat that highly pathogenic coronaviruses have on global health security and the imminent need to design an effective vaccine for prevention purposes. Although several attempts have been made to develop vaccines against human coronavirus infections since the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) in 2003, there is no available licensed vaccine yet. …”
Get full text
Article -
82
Livestock Vaccines: Principles, Types, and Important Factors to Consider
Published 2024-02-01Subjects: “…vaccines…”
Get full text
Article -
83
A novel platform for engineered AAV-based vaccines
Published 2025-03-01Subjects: Get full text
Article -
84
Tuberculosis vaccines and therapeutic drug: challenges and future directions
Published 2025-01-01“…The hurdles in TB vaccine and therapeutic development encompass overcoming antigen diversity, enhancing vaccine effectiveness across diverse populations, and advancing novel vaccine platforms. …”
Get full text
Article -
85
-
86
-
87
The role of new hepatitis B vaccines in South Africa
Published 2024-02-01Subjects: Get full text
Article -
88
Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis
Published 2017-01-01Get full text
Article -
89
Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines
Published 2024-12-01Subjects: Get full text
Article -
90
Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity
Published 2016-01-01Get full text
Article -
91
Patent Dimensions in the Development and Production of COVID-19 Vaccines
Published 2021-05-01“…Abstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. …”
Get full text
Article -
92
COVID-19 Booster Vaccines Administration in Different Countries
Published 2021-12-01“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in the COVID-19 global pandemic had consequently led to the development of different types of COVID-19 vaccines, including the messenger RNA (mRNA) vaccines, inactivated virus vaccines, a protein subunit vaccine, and viral vector recombinant vaccines. …”
Get full text
Article -
93
Updates on the development of vaccines and therapeutic options against rabies
Published 2020-08-01“… Even though rabies has been claiming more than 50,000 deaths annually worldwide, it is considered as a vaccine-preventable viral disease. More than 95 % of the total human rabies cases are caused by dogs. …”
Get full text
Article -
94
Potential and development of cellular vesicle vaccines in cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
95
Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
Published 2016-01-01“…Recently it was demonstrated that tumors induce specific changes to the surface of human endothelial cells thereby providing the basis for designing endothelial cell-based vaccines that directly target antigens expressed by the tumor endothelium. …”
Get full text
Article -
96
-
97
-
98
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease
Published 2025-01-01Subjects: Get full text
Article -
99
Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
100
Improved population coverage of the human papillomavirus vaccine after implementation of a school-based vaccination programme: the Singapore experience
Published 2023-05-01“…Despite constant efforts to encourage vaccination, local HPV vaccine uptake remains low. Universal mass vaccination is a proven cost-effective method to reduce the cervical cancer disease burden. …”
Get full text
Article